After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen.

在致耐受方案，抑制剂从宿主撤离，宿主仍能保持对在于耐受原上的原表位的特异耐受。

E2 protein, including hypervariable region 1 (HVR1) in the N-terminal region, contains some epitopes that can induce neutralizing antibodies.

包括高变区的E2蛋白含有中和抗原表位，能诱导机体产生中和抗体。